Membrane-associated heparan sulfate is not required for rAAV-2 infection of human respiratory epithelia

Virology Journal

Volumn 3, Issue , 2006, Pages

  Boyle, Michael P ^a   Enke, Raymond A ^a   Reynolds, Jeffrey B ^a   Mogayzel Jr , Peter J ^a   Guggino, William B ^a   Zeitlin, Pamela L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; HEPARIN LYASE; PROTEOHEPARAN SULFATE;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; CELL LINE; CELL MEMBRANE; CHINESE HAMSTER; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; NONHUMAN; OVARY CELL CULTURE; RESPIRATORY EPITHELIUM; VIRUS INFECTION;

ANIMALS; BRONCHI; CELL LINE; CHO CELLS; CHONDROITIN SULFATES; CRICETINAE; DEPENDOVIRUS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MEMBRANE PROTEINS; POLYSACCHARIDE-LYASES; TRACHEA;

ADENO-ASSOCIATED VIRUS - 2; CRICETULUS GRISEUS;

EID: 33646557048     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-29     Document Type: Article

References (27)

1. Monahan PE, Samulski RJ: AAV vectors: is clinical success on the horizon? Gene Ther 2000, 7:24-30.
2. Summerford C, Samulski RJ: Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998, 72:1438-1445.
3. Opie SR, Warrington KH Jr, Agbandje-McKenna M, Zolotukhin S, Muzyczka N: Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J Virol 2003, 77:6995-7006.
4. Kern A, Schmidt K, Leder C, Muller OJ, Wobus CE, Bettinger K, der Lieth CW, King JA, Kleinschmidt JA: Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol 2003, 77:11072-11081.
5. Negishi A, Chen J, McCarty DM, Samulski RJ, Liu J, Superfine R: Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopy. Glycobiology 2004, 14:969-977.
6. Esko JD, Lindahl U: Molecular diversity of heparan sulfate. J Clin Invest 2001, 108:169-173.
7. Forsberg E, Kjellen L: Heparan sulfate: lessons from knockout mice. J Clin Invest 2001, 108:175-180.
8. Patel M, Yanagishita M, Roderiquez G, Bou-Habib DC, Oravecz T, Hascall VC, Norcross MA: Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retroviruses 1993, 9:167-174.
9. Boyle KA, Compton T: Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J Virol 1998, 72:1826-1833.
10. Song BH, Lee GC, Moon MS, Cho YH, Lee CH: Human cytomegalovirus binding to heparan sulfate proteoglycans on the cell surface and/or entry stimulates the expression of human leukocyte antigen class I. J Gen Virol 2001, 82:2405-2413.
11. Immergluck LC, Domowicz MS, Schwartz NB, Herold BC: Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells. J Gen Virol 1998, 79(Pt 3):549-559.
12. WuDunn D, Spear PG: Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 1989, 63:52-58.
13. Feldman SA, Audet S, Beeler JA: The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J Virol 2000, 74:6442-6447.
14. Sattentau QJ, Dalgleish AG, Weiss RA, Beverley PC: Epitopes of the CD4 antigen and HIV infection. Science 1986, 234:1120-1123.
15. Qiu J, Handa A, Kirby M, Brown KE: The interaction of heparin sulfate and adeno-associated virus 2. Virology 2000, 269:137-147.
16. Bartlett JS, Wilcher R, Samulski RJ: Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol 2000, 74:2777-2785.
17. Summerford C, Bartlett JS, Samulski RJ: AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999, 5:78-82.
18. Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A: Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999, 5:71-77.
19. Conrad CK, Allen SS, Afione SA, Reynolds TC, Beck SE, Fee-Maki M, Barrazza-Ortiz X, Adams R, Askin FB, Carter BJ, Guggino WB, Flotte TR: Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther 1996, 3:658-668.
20. Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, Conrad CK, Brass-Ernst L, Humphries M, Sullivan K, Wetzel R, Taylor G, Carter BJ, Guggino WB: Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther 2003, 14:1079-1088.
21. Duan D, Yue Y, Yan Z, McCray PB Jr, Engelhardt JF: Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum Gene Ther 1998, 9:2761-2776.
22. Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF: Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest 2000, 105:1573-1587.
23. Esko JD, Stewart TE, Taylor WH: Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci U S A 1985, 82:3197-3201.
24. Lidholt K, Weinke JL, Kiser CS, Lugemwa FN, Bame KJ, Cheifetz S, Massague J, Lindahl U, Esko JD: A single mutation affects both N- acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfatebiosynthesis. Proc Natl Acad Sci U S A 1992, 89:2267-2271.
25. Suzuki S, Saito H, Yamagata T, Anno K, Seno N, Kawai Y, Furuhashi T: Formation of three types of disulfated disaccharides from chondroitin sulfates by chondroitinase digestion. J Biol Chem 1968, 243:1543-1550.
26. Zeitlin PL, Lu L, Rhim J, Cutting G, Stetten G, Kieffer KA, Craig R, Guggino WB: A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 1991, 4:313-319.
27. Auricchio A, Hildinger M, O'Connor E, Gao GP, Wilson JM: Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther 2001, 12:71-76.